Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines

S. M. Moghimi, Thomas Lars Andresen

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    The recent unexpected observation that complement activation helps turnout growth and progression has an important bearing on the future development of cancer nanomedicines for site-specific tumour targeting as these entities are capable of triggering complement. These issues are discussed and suggestions are provided for future design and development of safer and effective cancer nanomedicines.
    Original languageEnglish
    JournalMolecular Immunology
    Volume46
    Issue number8-9
    Pages (from-to)1571-1572
    ISSN0161-5890
    DOIs
    Publication statusPublished - 2009

    Keywords

    • Complement system
    • Nanoparticles
    • C5a
    • Cancer

    Fingerprint

    Dive into the research topics of 'Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines'. Together they form a unique fingerprint.

    Cite this